Supporting our findings in the Pdcd1−/− mice, where CD5 expression was elevated in the splenic CD8+ T cells, a recent report showed that blocking CD5 together with PD-1 substantially enhanced survival and tumour cell killing [79]. Here, CD8A is linked to neoplasm.